Oral iron chelating agent –
**Question:** Oral iron chelating agent -
A. Deferasirox
B. Deferoxamine
C. Deferiprone
D. Deferoxamine
**Core Concept:** Iron chelation therapy is a pharmacological treatment for excessive iron overload disorders, such as hemochromatosis and thalassemia. Chelating agents bind to and remove excess iron from the body, preventing its accumulation and potential harm.
**Why the Correct Answer is Right:** DFO (Deferoxamine) is a first-generation oral iron chelating agent, initially used for the treatment of iron overload in thalassemia. It works by binding to excess iron in the body and excreting it, thereby decreasing iron levels and preventing organ damage.
**Why Each Wrong Option is Incorrect:**
A. Deferasirox (Exjade) is a second-generation oral iron chelating agent, which has higher bioavailability and is easier to administer compared to DFO. It is indicated for treating hereditary hemochromatosis and secondary iron overload.
B. Deferoxamine (Desferal) is a second-generation oral iron chelating agent that is administered intravenously. It is more effective than DFO in chelating iron, but DFO serves as a suitable alternative due to its oral administration.
C. Deferiprone (L1) is a third-generation oral iron chelating agent, which is highly effective in chelating iron in thalassemia patients. DFO, being a first-generation agent, is less effective and has more side effects.
**Clinical Pearl:** In clinical practice, DFO is often chosen over Deferasirox due to its oral administration, which is more convenient for patients. However, Deferasirox may be preferred in specific cases, such as in patients with contraindications to intravenous administration or those unable to follow up for regular intravenous infusions.
**Correct Answer:** DFO (Deferoxamine) is the correct answer as it is a first-generation oral iron chelating agent. Although it is administered intravenously, it is a suitable alternative due to its availability. Deferasirox, deferiprone, and deferoxamine all serve as oral iron chelating agents, but DFO is a suitable alternative due to its availability.